Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV002937866 | SCV003260562 | benign | not provided | 2024-01-18 | criteria provided, single submitter | clinical testing | |
Ce |
RCV002937866 | SCV004126042 | likely benign | not provided | 2024-08-01 | criteria provided, single submitter | clinical testing | OBSCN: BS1 |
OMIM | RCV003152650 | SCV003841052 | risk factor | Rhabdomyolysis, susceptibility to, 1 | 2023-02-03 | no assertion criteria provided | literature only | |
Prevention |
RCV004750787 | SCV005351705 | uncertain significance | OBSCN-related disorder | 2024-03-29 | no assertion criteria provided | clinical testing | The OBSCN c.23385_23386delCA variant is predicted to result in an in-frame deletion (p.Ser7796fs). To our knowledge, this variant has not been reported in the literature. This variant is reported in 0.93% of alleles in individuals of European (Finnish) descent in gnomAD. At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. |